Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Mega

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|August 30, 2011
A new era for anticoagulation in atrial fibrillationJessica L Mega
Lancet (London, England)|March 18, 2015
Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatmentsJessica L Mega, Tabassome Simon
Journal of the American College of Cardiology|November 6, 2010
Another step on the road to tailored antiplatelet therapyStephen D Wiviott, Jessica L Mega
Clinical Chemistry|April 3, 2014
Genotype-guided dosing of warfarinJessica L Mega, Robert P Giugliano
Circulation|May 29, 2014
Dual antiplatelet therapy for heart diseaseEdward T Carreras, Jessica L Mega
Hematology. American Society of Hematology. Education Program|February 20, 2015
Pharmacogenomics of antiplatelet drugsMarc S Sabatine, Jessica L Mega
Cardiology and Therapy|August 20, 2014
Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular diseaseEdward T Carreras, Jessica L Mega
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2015
Role of oral anticoagulants in patients after an acute coronary syndromeEdward T Carreras, Jessica L Mega
Circulation|December 25, 2014
Duration of anticoagulation for venous thromboembolic eventsNathaniel R Smilowitz, Jessica L Mega, Jeffrey S Berger
JAMA|November 17, 2014
Population and personalized medicine in the modern eraJessica L Mega, Marc S Sabatine, Elliott M Antman
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|August 30, 2011
A new era for anticoagulation in atrial fibrillationJessica L Mega
Lancet (London, England)|March 18, 2015
Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatmentsJessica L Mega, Tabassome Simon
Journal of the American College of Cardiology|November 6, 2010
Another step on the road to tailored antiplatelet therapyStephen D Wiviott, Jessica L Mega
Clinical Chemistry|April 3, 2014
Genotype-guided dosing of warfarinJessica L Mega, Robert P Giugliano
Circulation|May 29, 2014
Dual antiplatelet therapy for heart diseaseEdward T Carreras, Jessica L Mega
Hematology. American Society of Hematology. Education Program|February 20, 2015
Pharmacogenomics of antiplatelet drugsMarc S Sabatine, Jessica L Mega
Cardiology and Therapy|August 20, 2014
Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular diseaseEdward T Carreras, Jessica L Mega
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2015
Role of oral anticoagulants in patients after an acute coronary syndromeEdward T Carreras, Jessica L Mega
Circulation|December 25, 2014
Duration of anticoagulation for venous thromboembolic eventsNathaniel R Smilowitz, Jessica L Mega, Jeffrey S Berger
JAMA|November 17, 2014
Population and personalized medicine in the modern eraJessica L Mega, Marc S Sabatine, Elliott M Antman
Pageof 7